Department of Pathology, UW Medicine, University of Washington
Charles E. Alpers, MD
Professor and Interim Chair of Pathology
About the Department of Pathology
UW Medicine Pathology brings together state-of-the-art technology and highly trained personnel, including nationally and internationally recognized faculty to provide comprehensive diagnostic and personalized service to physicians, community hospitals, independent laboratories, and other health care organizations. We combine sophisticated testing and informatics capabilities of fully accredited laboratories with the resources of an academic and teaching institution in its delivery of pathology services.
In the News
Dr. Peter Rabinovitch talks about his life long connection with the University of Washington and his research in the Biology of Aging.
Jessica Young, PhD, Assistant Professor of Pathology, studies the molecular and cellular mechanisms behind late-onset sporadic Alzheimer’s disease (SAD), the most common neurodegenerative disorder. The Young Lab's work is featured in an article on the UW Medicine Huddle and Newsroom websites.
The Zhang Lab, led by Dr. Jing Zhang, MD, PhD, Professor of Pathology at UW Medicine, is aiming to be the first group to develop reliable, accurate, and reproducible blood biomarkers in the field for Alzheimer’s and Parkinson’s diseases. The Zhang Lab's work is featured on the UW Medicine Memory and Brain Wellness Center website.
Case in point: A drug for cancer was found to extend lives of people with progeria, and may have broader use in cardiovascular health.
September 27, 2019 at 1:00pm - September 28, 2019 at 4:00pm
The retreat will be held at Semiahmoo Resort. Semiahmoo Resort is located in Blaine, Washington about 90 minutes north of Seattle. Semiahmoo has outdoor activities such as skiing, hiking/snowshoeing nearby as well as options to relax and pamper yourself. The Departments will provide accommodations for Friday night.
October 2, 2019 at 1:30pm - 2:30pm | UWMC, NE110
Pathology Grand Rounds Presents: “Evidence from Tumors and Families for Precision Diagnostics in Cancer Predisposition Syndromes”